Generics, Branded Generics and Biosimilars: NHS update

Friday 13th September 2024 13:00 - 14:00 (BST)


Masterclass Details:

Our panel of industry leaders came together for a deep dive into the current and future landscape of Generics, Branded Generics, and Biosimilars, exploring the pressing issues, opportunities, and emerging trends in the sector.

With a focus on the evolving political environment, we examined how the recent government changes could impact policy, procurement, and patient outcomes. The discussion covered the importance of continued engagement between the government and the off-patent sector, emphasising the vital role of generics and biosimilars in ensuring affordable healthcare.

Our speakers also addressed the challenges of maintaining a sustainable supply chain, highlighting the pressures caused by low-cost reimbursement models. The potential for biosimilars to increase patient access and reduce costs was another key topic, along with the future role of branded generics in hospital care.

Key Learning Objectives:

  • The landscape of generics, branded generics, and biosimilars in the NHS.
  • Clinical and economic considerations for the use of generics, branded generics, and biosimilars.
  • The latest developments in the research and development of generic and biosimilar medicines.
  • The implications of the evolving NHS landscape on industry.

 

  • Date and time

    13th Sep 2024 13:00 – 14:00 (BST)

Generics, Branded Generics and Biosimilars: NHS update

Speakers

We work with more than 200 leading Life Sciences companies including:

Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.

Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.

Marsha Gray, Training Specialist

Boehringer Ingelheim Ltd

We have been partnered with LSAA for several years now which has enabled our team members to develop their competencies and capabilities.

With over 700 learning modules, regular webinars on highly relevant topics across the UK, the opportunity to engage with expert speakers after events and regular blogs and newsletters, the platform is a highly valued resource at Ferring.

The team also provides regular usage statistics so we can understand the hot topics in Ferring and enable colleagues to share knowledge and experience with each other.

Paul Runeckles, Director of Execution Excellence

Ferring

Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.

Life Science Access Academy training is topical and a good fit for the faced paced healthcare market.

Simon Warden, National Sales Manager

Frontier Medical Group

I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.

The content is always kept up to date and there is huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.

Richard Edmonds

Gedeon Richter Women's Health

The variety and relevancy of content brings value to many different roles across the healthcare industry.

I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.

Robb Sayers, UK Capability Lead

ViiV Healthcare